» Articles » PMID: 31504827

Cerebrospinal Fluid Shunting Improves Long-Term Quality of Life in Idiopathic Normal Pressure Hydrocephalus

Overview
Journal Neurosurgery
Specialty Neurosurgery
Date 2019 Sep 11
PMID 31504827
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The short- and long-term impact of cerebrospinal fluid shunting on quality of life (QoL) in idiopathic normal pressure hydrocephalus (INPH) is poorly understood.

Objective: To investigate QoL in shunted INPH patients compared to the population and to investigate which factors influence QoL in INPH.

Methods: INPH patients consecutively shunted in Sweden during 2008-2010 were scrutinized. Population-based controls were age- and sex-matched to the patients. Included participants were the following: 176 INPH patients and 368 controls. QoL was assessed using the EuroQol 5-dimension 5-level (EQ5D5L) instrument, which measures overall QoL and health status in 5 dimensions. Independency (accommodation and/or need for in-home care) and comorbidities were assessed. Patients were followed up 6-45 mo after surgery (mean follow-up time: 21 mo).

Results: Shunting improved QoL (P < .001) and health status in all dimensions (P < .005). Shunted INPH patients had lower QoL than controls (P < .001). The patients' health status in mobility, self-care, daily activities, and anxiety/depression was worse than the controls both before and after surgery (P < .001). The main predictors of low QoL in INPH were symptoms of depression (P < .001) and severity of gait disturbance (P = .001). Fewer INPH patients than controls lived independently (45% vs 85%, P < .001). Time after shunting had no influence on QoL.

Conclusion: QoL remains improved in shunted INPH patients at a mean follow-up time of 21 mo, but the patients do not reach the same QoL as the population. Symptoms of depression and severity of gait disturbance are the strongest predictors of low QoL in INPH.

Citing Articles

Discrepancies in Subjective Perceptions of Hydrocephalus Management and Self-Reported Outcomes.

Zipfel J, Filip Z, Kohlmann-DellAcqua C, Noell S, Trakolis L J Clin Med. 2024; 13(23).

PMID: 39685663 PMC: 11642199. DOI: 10.3390/jcm13237205.


Survival After Shunt Therapy in Normal-Pressure Hydrocephalus: A Meta-Analysis of 1614 Patients.

Wach J, Guresir A, Guresir E, Vychopen M Neurol Int. 2024; 16(6):1438-1450.

PMID: 39585066 PMC: 11587452. DOI: 10.3390/neurolint16060107.


Depressive symptoms, functional impairment, and health-related quality of life in idiopathic normal pressure hydrocephalus: A population-based study.

Andersson J, Maripuu M, Sjovill M, Lindam A, Laurell K PLoS One. 2024; 19(7):e0308079.

PMID: 39078825 PMC: 11288432. DOI: 10.1371/journal.pone.0308079.


Toward the "Perfect" Shunt: Historical Vignette, Current Efforts, and Future Directions.

Podgorsak A, Flurenbrock F, Trimmel N, Korn L, Oertel M, Stieglitz L Adv Tech Stand Neurosurg. 2024; 50:1-30.

PMID: 38592526 DOI: 10.1007/978-3-031-53578-9_1.


Gait, falls, cognitive function, and health-related quality of life after shunt-treated idiopathic normal pressure hydrocephalus-a single-center study.

Hallqvist C, Gronstedt H, Arvidsson L Acta Neurochir (Wien). 2022; 164(9):2367-2373.

PMID: 35831723 PMC: 9427897. DOI: 10.1007/s00701-022-05309-4.